As the beginning of this study, we preliminarily investigated the role of CDKL3 in prostate cancer progression by analyzing its expression in 156 prostate cancer tumor tissues and 32 adjacent normal tissues. This evidence concerns the gene CDKL3 and prostate carcinoma.